Cancer deaths projected to almost double by 2050, with more than twofold increase for older men and low-, medium HDI countries<\/p>\n<\/h3>\n
By Elana Gotkine HealthDay Reporter<\/b><\/p>\n
<\/b><\/p>\n
MONDAY, Aug. 12, 2024 (HealthDay News) — There are substantial disparities in cancer cases and deaths among men, which are projected to widen by 2050, according to a study published online Aug. 12 in Cancer<\/em>.<\/p>\n Habtamu Mellie Bizuayehu, Ph.D., from the University of Queensland in Brisbane, Australia, and colleagues analyzed 30 cancer types among men in 2022 using GLOBOCAN estimates for men in 185 countries\/territories worldwide and estimated projections for 2050. By dividing age-standardized mortality rates by incidence rates, mortality-to-incidence ratios (MIRs) were calculated.<\/p>\n The researchers found that a high MIR was seen among older men (aged 65 years and older), for rare cancer types, and in countries with a low Human Development Index (HDI; 61, 91, and 74 percent, respectively) in 2022. Cancer cases are projected to increase from 10.3 to 19 million between 2022 and 2050 (\u00e2\u0089\u00a584 percent), while deaths are projected to increase from 5.4 to 10.5 million (\u00e2\u0089\u00a593 percent), with a more than twofold increase among men aged 65 years and older and for low- and medium-HDI countries\/territories (\u00e2\u0089\u00a5117 and \u00e2\u0089\u00a5160 percent, respectively). Among working-age groups and very high-HDI countries\/territories, cancer cases and deaths are projected to increase (\u00e2\u0089\u00a539 and \u00e2\u0089\u00a550 percent, respectively).<\/p>\n “A national and international collaboration, as well as a coordinated multisectoral approach, are essential to improve current cancer outcomes and to reverse the anticipated rise in cancer burden by 2050,” Bizuayehu said in a statement.<\/p>\n